The femtech track explored innovations supporting women’s health. Companies that presented addressed a wide range of issues, spanning everything from fertility, maternal health, menopause, menstrual health, oncology, pelvic health, sexual health, and more. The presentations were accompanied by a lively audience chat on the trials and tribulations of those in the women’s health-innovation field.
Speakers include: Faz Bashi, MD, Lead Venture Investor with Portfolia's FemTech Fund I & II; Bipin Dalmia, Vice President Business Development, Ferring Pharmaceuticals; Linda Greub, Avestria Co-Founder and Managing Partner; Simon Holland, VP Women’s Health Commercial Lead for Organon & Co., a wholly owned subsidiary of Merck & Co., Inc.; Maria Velissaris, Founding Partner, SteelSky Ventures LLC; Eli Weinberg, Partner, McKinsey & Company; Alice Zheng, Consultant, McKinsey & Company